TheraRadar

Pharma Intelligence, Simplified

Landscape Gastrointestinal

Peptic Ulcer

334 clinical trials

117 active
/
334 total (since 2015)
19
Phase 1 Active
75 total
51
Phase 2 Active
135 total
24
Phase 3 Active
82 total
35
Phase 4 Active
78 total

Top Sponsors (Industry)

Sorted by active Active Done Failed
Johnson & Johnson 7 4 1
Sanofi 4 0 0
Cellution Biologics 3 0 0
MediWound Ltd 2 2 0
TR Therapeutics 2 0 0
Applied Biologics, LLC 2 0 0
BioLab Holdings 2 0 0
Tiger Biosciences, LLC. 2 0 0
Bristol-Myers Squibb 1 3 1
RHEACELL GmbH & Co. KG 1 3 1
GSK 1 2 2
Oneness Biotech Co., Ltd. 1 0 3
Merck 1 2 0
Onconic Therapeutics Inc. 1 2 0
Addpharma Inc. 1 1 0
NCT07196748 RECRUITING
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Janssen Research & Development, LLC n=882
NCT05528510 ACTIVE NOT RECRUITING
A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
Janssen Research & Development, LLC n=418
NCT06260163 ACTIVE NOT RECRUITING
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
Janssen Research & Development, LLC n=112
NCT06663332 RECRUITING
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Janssen Research & Development, LLC n=196
NCT06707090 RECRUITING
Tissue Repair Gel in Venous Leg Ulcers (US)
TR Therapeutics n=312
NCT07391319 RECRUITING
The Prospective, Double-blind, Multicenter, Placebo-controlled, Randomized, Comparative Clinical Trial
JSC NextGen n=144
NCT03596645 ACTIVE NOT RECRUITING
A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
Janssen Research & Development, LLC n=84
NCT05092269 RECRUITING
A Long-term Extension Study of Ustekinumab in Pediatric Participants
Janssen Research & Development, LLC n=151
NCT07311070 ENROLLING BY INVITATION
Treatment of Basal Cell Carcinoma (BCC) of the Skin, of the Morpheiform, Infiltrative, and Noduloulcerative Types in Inoperable Patients and Not Suitable for Radiotherapy Using Formulated Methylene Blue
Daryoush Hamidi Alamdari, PhD n=20
NCT06651281 RECRUITING
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Merck Sharp & Dohme LLC n=1,380
NCT05076175 RECRUITING
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Bristol-Myers Squibb n=120
NCT07223892 NOT YET RECRUITING
Efficacy of Carbonlife Amniotic Tissue Product in the Treatment of Chronic Wounds
Bardia Anvar n=600
NCT06658002 RECRUITING
Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A
University of California, San Francisco n=150
NCT05930210 RECRUITING
A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer
Energenesis Biomedical Co., Ltd. n=230
NCT06489028 ACTIVE NOT RECRUITING
Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Therapy-resistant CVU (Phase III)
RHEACELL GmbH & Co. KG n=250
NCT06910579 RECRUITING
Oxygenated Gel Therapy in the Management of Oral Aphthous Ulcers
British University In Egypt n=30
NCT06531512 RECRUITING
Evaluate the Efficacy and Safety of Xianglei Tangzu Gao for the Treatment of Wagner Grade II Diabetic Foot Ulcers
Oneness Biotech Co., Ltd. n=120
NCT06297967 RECRUITING
Acetic Acid 2% Solution for Skin Ulcers
Consorci Sanitari de l'Alt Penedès i Garraf n=104
NCT06660693 RECRUITING
Comparison of Medical RESCUE Strategies for Patients With Steroid-refractory Acute Severe Ulcerative Colitis
McMaster University n=134
NCT06284876 RECRUITING
Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer
Il-Yang Pharm. Co., Ltd. n=416
NCT06568627 RECRUITING
A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)
MediWound Ltd n=216
NCT06707103 RECRUITING
Tissue Repair Gel in Venous Leg Ulcers in AU/US
TR Therapeutics n=312
NCT06786403 NOT YET RECRUITING
The Effects of Bromelain Supplement in Patients with Diabetic Foot Ulcers
Dr Azita Hekmatdoost n=70
NCT06439563 RECRUITING
Study to Evaluate the Efficacy and Safety of JP-1366 in the Prevention of NSAIDs-Induced Peptic Ulcers
Onconic Therapeutics Inc. n=364
NCT03553563 COMPLETED
A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer
AstraZeneca n=50
NCT03482635 COMPLETED
BI655130 (SPESOLIMAB) Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis
Boehringer Ingelheim n=98
NCT03915769 COMPLETED
To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis
Celgene n=198
NCT02563522 TERMINATED
Safety and Efficacy Study of Engensis (VM202) in the Treatment of Chronic Non-Healing Foot Ulcers
Helixmith Co., Ltd. n=44
NCT04779307 COMPLETED
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC)
Takeda n=121
NCT02731638 COMPLETED
Mycotic Antimicrobial Localized Injection for Treatment of Corneal Ulcers
University of California, San Francisco n=70
NCT04569409 COMPLETED
Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Wagner Grade 2 Foot Ulcers.
Anterogen Co., Ltd. n=104
NCT07186114 COMPLETED
A Prospective Study on the Therapeutic Outcomes of Mebo and Tantum Verde in Patients With Oral Mucositis
Cairo University n=36
NCT04469686 COMPLETED
Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories
Cristcot LLC n=200
NCT04630028 COMPLETED
A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Janssen Research & Development, LLC n=112
NCT05561140 TERMINATED
Resolution of Sickle Cell Leg Ulcers With Voxelotor
Pfizer n=88
NCT02570321 COMPLETED
Cross-linking for Corneal Ulcers Treatment Trial
University of California, San Francisco n=147
NCT03387774 COMPLETED
Efficacy of Ulinastatin for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients
Sun Yat-sen University n=179
NCT03282981 COMPLETED
Beta Adrenergic Antagonist for the Healing of Chronic DFU
VA Office of Research and Development n=48
NCT02407236 COMPLETED
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
Janssen Research & Development, LLC n=961
NCT02620046 COMPLETED
A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease
Takeda n=746
NCT04450693 COMPLETED
Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU II)
BioTissue Holdings, Inc n=106
NCT04962139 TERMINATED
Evaluate the Safety and Efficacy of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers
Oneness Biotech Co., Ltd. n=12
NCT05656092 COMPLETED
A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric Ulcer
Hanmi Pharmaceutical Company Limited n=199
NCT05764876 COMPLETED
Repurposing Clinically Approved Drugs for Yaws with an Insight Into the Cutaneous Ulcer Disease Syndrome (Trep-AByaws)
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia n=465
NCT05281562 TERMINATED
Immunonutrition for Diabetic Foot Ulcers
Prisma Health-Midlands n=1
NCT05607979 COMPLETED
Restoring Tissue and Evaluating Novel Treatments for Efficacy in Wounds
Lavior Pharma Inc. n=75
NCT04274049 COMPLETED
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-2)
Beijing Northland Biotech. Co., Ltd. n=242
NCT04275323 COMPLETED
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-1)
Beijing Northland Biotech. Co., Ltd. n=302
NCT05227833 COMPLETED
Vonoprazan Efficacy to Prevent Post Variceal Band Ligation Ulcer
Alexandria University n=284
NCT05448001 COMPLETED
Clinical Trial to Evaluate the Efficacy and Safety of JP-1366 in Patients With Gastric Ulcer
Onconic Therapeutics Inc. n=329
NCT04784910 COMPLETED
Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic Ulcer
Daewoong Pharmaceutical Co. LTD. n=423
NCT04176120 COMPLETED
Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU)
BioTissue Holdings, Inc n=220
NCT03998436 COMPLETED
Phase 3 Study to Evaluate the Safety and Efficacy of Galnobax® in Treating Diabetic Foot Ulcers
Novalead Pharma Private Limited n=176
NCT03370874 COMPLETED
Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers.
Anterogen Co., Ltd. n=150
NCT03531892 COMPLETED
A Study to Evaluate the Safety and Efficacy of AJM300 in Participants With Active Ulcerative Colitis
EA Pharma Co., Ltd. n=198
NCT03476876 COMPLETED
Comparative Effectiveness of Two Acellular Matrices (Dermacell vs. Integra) for Management of Deep Diabetic Foot Ulcers
Baylor College of Medicine n=34
NCT05841394 COMPLETED
A Multi-center, Double-blinding, Parallel and Positive-controlled Phase III Clinical Trial for Efficacy and Safety Evaluation of Ilaprazole Sodium for Injection on Prevention of Stress Ulcer Bleeding
Livzon Pharmaceutical Group Inc. n=449
NCT05010954 COMPLETED
Efficacy and Safety of LXI-15028 Comparing With Lansoprazole in the Treatment of Duodenal Ulcer
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. n=400
NCT02769494 WITHDRAWN
The Efficacy of Topical Mesalazine Sustained-Release Tablets in Crohn's Disease Patients With Oral Ulcer
Xijing Hospital of Digestive Diseases
NCT02611830 COMPLETED
Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative Colitis
Takeda n=383
NCT02447172 COMPLETED
Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers
Innocoll n=524
NCT02427802 COMPLETED
Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers
Innocoll n=612
NCT03050307 COMPLETED
Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori Infection
Takeda n=234
NCT02789033 COMPLETED
Efficacy of the Combination of Isosorbide Dinitrate Spray and Chitosan in Diabetic Foot Ulcers
University of Guadalajara n=68
NCT04140591 TERMINATED
Proton Pump Inhibitor Plus Propranolol Versus Proton Pump Inhibitor Alone on Peptic Ulcer Healing in Patients With Liver Cirrhosis
Taipei Veterans General Hospital, Taiwan n=10
NCT03412682 COMPLETED
To Evaluate the Efficacy and Safety of FE 999315 in Japanese Subjects With Mild to Moderate Active Ulcerative Colitis
Ferring Pharmaceuticals n=274
NCT03050359 COMPLETED
Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori Infection
Takeda n=533
NCT02667327 TERMINATED
A Study of Granexin Gel in the Treatment of Diabetic Foot Ulcer
Xequel Bio, Inc. n=124
NCT04310280 COMPLETED
Effects of Local Insulin on Varicose Ulcers for Wound Healing
Hospital Central "Dr. Ignacio Morones Prieto" n=13
NCT02213952 WITHDRAWN
PRP ULCERAS: Clinical Trial Phase III
Basque Health Service
NCT02497469 COMPLETED
An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis
Takeda n=771
NCT02761512 COMPLETED
Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Gastric Ulcer
HK inno.N Corporation n=306
NCT02158806 COMPLETED
Low Dose Aspirin for Venous Leg Ulcers
University of Auckland, New Zealand n=251
NCT02565745 TERMINATED
Skin Dressings Versus Lubrication to Prevent Pressure Ulcers: A Randomized Trial
Fundación Cardioinfantil Instituto de Cardiología n=689
NCT01840085 TERMINATED
Open-Label Study in Diabetic Foot Ulcers (DFU), to Evaluate Safety of 0.03% DSC127 Topical Gel in Chronic Use
Integra LifeSciences Corporation n=261
NCT02802995 TERMINATED
Safety And Efficacy Of Topical Platelet Rich Plasma And Thrombin Coagulum
University of Witwatersrand, South Africa n=15
NCT02571738 TERMINATED
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Osiris Therapeutics n=108
NCT02389010 COMPLETED
Clinical Efficacy of Platelet Gel From Cord Blood for the Treatment of Diabetic Foot Ulcers
Centro Nazionale Sangue n=50
NCT01982318 WITHDRAWN
A Prospective Randomized, Double-Blind, Placebo-Controlled Trial Comparing VitroGro® ECM to Placebo in Patients With Venous Leg Ulcers
Tissue Therapies Ltd.
NCT02625792 COMPLETED
Role of Hemostatic Powder (Endo-clotTM) in Prevention of Bleeding Within High Risk Patients After ESD
Yonsei University n=45
NCT02290327 COMPLETED
Re-Evaluating the Inhibition of Stress Erosions: Gastrointestinal Bleeding Prophylaxis In ICU
McMaster University n=91
NCT02004626 WITHDRAWN
Evaluate the Noninferiority of Medicines Treating Uninfected Pressure Ulcers.
Cristália Produtos Químicos Farmacêuticos Ltda.